Pharming Group N.V. (PHAR) Operating margin 2019–2025
Pharming Group N.V. (PHAR) operating margin by fiscal year — reported operating income divided by reported revenue.
6.9%FY2025 · since FY2019: 36.0% → 6.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 6.9% | +9.8 pp |
| FY2024 | -2.9% | -0.7 pp |
| FY2023 | -2.2% | -11.1 pp |
| FY2022 | 8.9% | +2.0 pp |
| FY2021 | 6.8% | -29.1 pp |
| FY2020 | 35.9% | -0.1 pp |
| FY2019 | 36.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice